BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,773,000 | – | 86,165 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $108,659,000 | 54.35% |
| Knoll Capital Management, LLC | 749,815 | $38,593,000 | 29.33% |
| VHCP Management II, LLC | 1,138,075 | $58,577,000 | 17.14% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,021,392 | $52,571,000 | 11.19% |
| Aisling Capital Management LP | 274,513 | $14,129,000 | 10.76% |
| Foresite Capital Management IV, LLC | 518,560 | $26,690,000 | 9.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 844,266 | $43,454,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 206,000 | $10,603,000 | 5.04% |
| ARS Investment Partners, LLC | 464,127 | $23,889,000 | 4.32% |
| Cormorant Asset Management, LP | 1,100,000 | $56,617,000 | 3.83% |